| Literature DB >> 20188578 |
Pritam Thapa1, Radha Karki1, Hoyoung Choi1, Jae Hun Choi1, Minho Yun1, Byeong-Seon Jeong1, Mi-Ja Jung2, Jung Min Nam2, Younghwa Na3, Won-Jea Cho4, Youngjoo Kwon2, Eung-Seok Lee1.
Abstract
A series of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives were designed, synthesized, and evaluated for their topoisomerase I and II inhibition and cytotoxic activity against several human cancer cell lines. Compounds 10-19 showed moderate topoisomerase I and II inhibitory activity and 20-29 showed significant topoisomerase II inhibitory activity. Structure-activity relationship study revealed that 4-(5-chlorofuran-2-yl)-2-(thiophen-3-yl) moiety has an important role in displaying topoisomerase II inhibition. Copyright 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20188578 DOI: 10.1016/j.bmc.2010.01.065
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641